International Conference on Clinical Laboratory Medicine, Pharmacy and Chemistry
ICCLMPC
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest developments in pharmaceutical chemistry, emphasizing innovative methodologies in drug design and synthesis. Participants will explore cutting-edge research that enhances the efficacy and safety of pharmaceutical compounds.
SDG 3
SDG 9
This session will delve into contemporary practices in clinical pharmacy, highlighting innovative approaches to patient care and medication management. Discussions will include the role of clinical pharmacists in optimizing therapeutic outcomes and improving healthcare delivery.
SDG 3
SDG 4
This track will cover advanced analytical techniques employed in laboratory medicine, focusing on their application in diagnostics and research. Participants will gain insights into the latest technologies that enhance the accuracy and reliability of laboratory results.
SDG 3
SDG 9
This session will explore the intersection of basic research and clinical application in pharmacy, emphasizing translational research methodologies. Attendees will discuss strategies for bridging the gap between laboratory discoveries and practical therapeutic solutions.
SDG 3
SDG 4
This track addresses the critical aspects of quality control in pharmaceutical manufacturing processes. Participants will examine regulatory standards and innovative practices that ensure the safety and efficacy of pharmaceutical products.
SDG 3
SDG 9
This session will highlight recent innovations in laboratory diagnostics, focusing on technologies that improve diagnostic accuracy and patient outcomes. Discussions will include the role of automation and artificial intelligence in enhancing laboratory efficiency.
SDG 3
SDG 9
This track will investigate sustainable practices within the pharmacy sector, addressing environmental and economic impacts. Participants will discuss strategies for promoting sustainability in pharmaceutical research and development.
SDG 12
SDG 13
This session will analyze current trends in the pharmaceutical industry, including market dynamics and emerging therapeutic areas. Attendees will explore the implications of these trends for research, development, and healthcare delivery.
SDG 3
SDG 9
This track will focus on the importance of drug safety and pharmacovigilance in ensuring patient well-being. Participants will discuss methodologies for monitoring adverse drug reactions and the regulatory frameworks that support drug safety.
SDG 3
SDG 16
This session will cover essential aspects of laboratory management and education, emphasizing best practices for training and development in laboratory settings. Discussions will include strategies for fostering a culture of continuous improvement and innovation.
SDG 4
SDG 9
This track will explore the role of molecular pharmacy in the drug development process, focusing on the design and evaluation of new therapeutic agents. Participants will discuss the integration of molecular techniques in enhancing drug efficacy and safety.
SDG 3
SDG 9